# Galmed Pharmaceuticals Ltd.: Form D filing

Galmed Pharmaceuticals Ltd., a pharmaceuticals company in Tel Aviv, Israel, filed a Form D with the SEC in 2017. The latest, on August 15, 2017, reports $100,000 sold of a $350,000 offering to 1 investor.

Find out what Galmed Pharmaceuticals Ltd. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Galmed%20Pharmaceuticals%20Ltd.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Galmed%20Pharmaceuticals%20Ltd.&page=%2Fdata%2Fform-d%2Fcompany%2Fgalmed-pharmaceuticals-ltd-1595353)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Galmed%20Pharmaceuticals%20Ltd.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Galmed%20Pharmaceuticals%20Ltd.&page=%2Fdata%2Fform-d%2Fcompany%2Fgalmed-pharmaceuticals-ltd-1595353)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 16 TIOMKIN STREET, Tel Aviv, Israel, 65783
- Phone: 972 3 693 8448
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Israel
- Year incorporated: 2013
- Revenue range: $1 - $1,000,000
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1595353

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Aug 15, 2017 | New notice | $350,000 | $100,000 | $250,000 | 1 | Aug 9, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1595353/000114420417043518/0001144204-17-043518-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Ran Oren | Director |  |
| Tali Gorfine | Executive Officer |  |
| Carol Brosgart | Director |  |
| David Sidransky | Director |  |
| Yohai Stenzler | Executive Officer |  |
| Liat Hayardeny | Executive Officer |  |
| Shmuel Nir | Director |  |
| William Marth | Director |  |
| Allen Baharaff | Executive Officer, Director |  |
| Chaim Hurvitz | Director |  |
| Tali Yaron-Eldar | Director |  |

[Every Form D from the week of Aug 14, 2017](https://specstream.ai/data/form-d/week/2017-08-14) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Galmed Pharmaceuticals Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).